These drugs are FDA-approved for type 2 diabetes and obesity, but growing evidence supports their use for rheumatoid arthritis, psoriatic arthritis, lupus, osteoarthritis, and metabolic/autoimmune diseases. Who should not take GLP-1 medications
This may have some potential benefits for managing type 2 diabetes and weight , but berberine isn't easily absorbed in the intestines, which limits how effective it can be
[4] Furthermore, upregulating GLP-1 decreases the secretion of glucagon , a hormone produced by pancreatic alpha cells that raises blood glucose levels by stimulating the conversion of liver glycogen to glucose
In this blog, well break down the role of these medications, explore their pros and cons, and help you understand if they might be a good option for you
Plus, it stops the production of glucagon , thus decreasing glucose from the liver